Hemodialysis patient. End-Stage renal disease
Conditions
Interventions
Intervention 1: Daily prescription of selenium supplement for 3 months. Intervention 2: Daily prescription of pacebo capsule containing starch for 3 months.
Treatment - Drugs
Daily prescription of selenium supplement for 3 months
Sponsors
Vice Chancellor for Research Affairs, Kermanshah University Of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: the patient's willingness to cooperate; at least 6 months passing after dialysis starting . Exclusion criteria: infectious diseases during last 3 months; steroidal and non-steroidal anti-inflammatory drugs; vitamins E, C and zinc usage within two months before the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Selenium. Timepoint: 90 days. Method of measurement: By cell counter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quantity CRP. Timepoint: 3 months later. Method of measurement: Cell counter.;T3RU. Timepoint: 3months later. Method of measurement: Cell counter.;T4. Timepoint: 3months later. Method of measurement: Cell counter.;TSH. Timepoint: 3months later. Method of measurement: Cell counter.;ESR. Timepoint: 3months later. Method of measurement: Cell counter.;Ferritin. Timepoint: 3months later. Method of measurement: Cell counter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Kanan Nikseresht
Kermanshah University of Medical Sciences
Outcome results
None listed